These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8615428)

  • 21. Tardive dystonia induced by risperidone.
    Krebs MO; Olie JP
    Can J Psychiatry; 1999 Jun; 44(5):507-8. PubMed ID: 10389620
    [No Abstract]   [Full Text] [Related]  

  • 22. Side effect profiles of new antipsychotic agents.
    Casey DE
    J Clin Psychiatry; 1996; 57 Suppl 11():40-5; discussion 46-52. PubMed ID: 8941170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluoxetine and extrapyramidal side effects.
    Fishbain DA
    Am J Psychiatry; 1996 Mar; 153(3):449. PubMed ID: 8610852
    [No Abstract]   [Full Text] [Related]  

  • 24. Risperidone-induced tardive dyskinesia.
    Silberbauer C
    Pharmacopsychiatry; 1998 Mar; 31(2):68-9. PubMed ID: 9562211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chorea and tardive dyskinesia in a patient taking risperidone.
    Carroll NB; Boehm KE; Strickland RT
    J Clin Psychiatry; 1999 Jul; 60(7):485-7. PubMed ID: 10453805
    [No Abstract]   [Full Text] [Related]  

  • 26. Tardive dyskinesia in older patients.
    Jeste DV
    J Clin Psychiatry; 2000; 61 Suppl 4():27-32. PubMed ID: 10739328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risperidone-induced tardive dyskinesia.
    Buzan RD
    Am J Psychiatry; 1996 May; 153(5):734-5. PubMed ID: 8615429
    [No Abstract]   [Full Text] [Related]  

  • 28. Tardive dyskinesia associated with fluoxetine.
    Sandler NH
    J Clin Psychiatry; 1996 Feb; 57(2):91. PubMed ID: 8591977
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical relationship of extrapyramidal symptoms and tardive dyskinesia.
    Andrew HG
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S76-80. PubMed ID: 7874668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tardive dyskinesia circa 2006.
    Kane JM
    Am J Psychiatry; 2006 Aug; 163(8):1316-8. PubMed ID: 16877639
    [No Abstract]   [Full Text] [Related]  

  • 31. Risperidone and tardive dyskinesia: a case report.
    Addington DE; Toews JA; Addington JM
    J Clin Psychiatry; 1995 Oct; 56(10):484-5. PubMed ID: 7559377
    [No Abstract]   [Full Text] [Related]  

  • 32. Tardive dyskinesia rates with atypical antipsychotics in older adults.
    Jeste DV
    J Clin Psychiatry; 2004; 65 Suppl 9():21-4. PubMed ID: 15189108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tardive dyskinesia in a patient taking haloperidol and fluoxetine.
    Stein MH
    Am J Psychiatry; 1991 May; 148(5):683. PubMed ID: 2018175
    [No Abstract]   [Full Text] [Related]  

  • 34. Risperidone-induced tardive dyskinesia and parkinsonism.
    Gwinn KA; Caviness JN
    Mov Disord; 1997 Jan; 12(1):119-21. PubMed ID: 8990067
    [No Abstract]   [Full Text] [Related]  

  • 35. Rabbit syndrome and tardive dyskinesia: two complications of chronic neuroleptic treatment.
    Schwartz M; Weller B; Erdreich M; Sharf B
    J Clin Psychiatry; 1995 May; 56(5):212. PubMed ID: 7737962
    [No Abstract]   [Full Text] [Related]  

  • 36. Fluoxetine induced dyskinesia.
    Mander A; McCausland M; Workman B; Flamer H; Christophidis N
    Aust N Z J Psychiatry; 1994 Jun; 28(2):328-30. PubMed ID: 7993290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia.
    Casey DE
    Psychiatr Clin North Am; 1993 Sep; 16(3):589-610. PubMed ID: 8105453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nasal bleeding associated with fluoxetine and risperidone interaction: a case report.
    Mowla A; Dastgheib SA; Ebrahimi AA; Pani A
    Pharmacopsychiatry; 2009 Sep; 42(5):204-5. PubMed ID: 19724985
    [No Abstract]   [Full Text] [Related]  

  • 39. Evidence that early extrapyramidal symptoms predict later tardive dyskinesia: a prospective analysis of 10,000 patients in the European Schizophrenia Outpatient Health Outcomes (SOHO) study.
    Tenback DE; van Harten PN; Slooff CJ; van Os J
    Am J Psychiatry; 2006 Aug; 163(8):1438-40. PubMed ID: 16877660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroleptic discontinuation and tardive dyskinesia risk.
    Sherr JD; Medoff D; Thaker G
    Am J Psychiatry; 1999 Jul; 156(7):1125-6. PubMed ID: 10401483
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.